Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer

Author:

Cirkel Geert A.1,Hamberg Paul2,Sleijfer Stefan3,Loosveld Olaf J. L.4,Dercksen M. Wouter5,Los Maartje6,Polee Marco B.7,van den Berkmortel Franchette8,Aarts Maureen J.9,Beerepoot Laurens V.10,Groenewegen Gerard1,Lolkema Martijn P.11,Tascilar Metin12,Portielje Johanna E. A.13,Peters Frank P. J.14,Klümpen Heinz-Josef15,van der Noort Vincent16,Haanen John B. A. G.17,Voest Emile E.18,

Affiliation:

1. University Medical Center Utrecht, Department of Medical Oncology, Utrecht, the Netherlands

2. Franciscus Gasthuis, Department of Medical Oncology, Rotterdam, the Netherlands

3. Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands

4. Amphia Hospital, Department of Medical Oncology, Breda, the Netherlands

5. Maxima Medical Center, Department of Medical Oncology, Eindhoven, the Netherlands

6. St Antonius Hospital, Department of Medical Oncology, Nieuwegein, the Netherlands

7. Medical Center Leeuwarden, Department of Medical Oncology, Leeuwarden, the Netherlands

8. Zuyderland Medical Center, Department of Medical Oncology, Heerlen, the Netherlands

9. Maastricht University Medical Center, Department of Medical Oncology, Maastricht, the Netherlands

10. Elisabeth Tweesteden Hospital, Department of Medical Oncology, Tilburg, the Netherlands

11. University Medical Center Utrecht, Department of Medical Oncology, Utrecht, the Netherlands3Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands

12. Isala Clinics, Department of Medical Oncology, Zwolle, the Netherlands

13. Haga Hospital, Department of Medical Oncology, Den Haag, the Netherlands

14. Zuyderland Medical Center, Department of Medical Oncology, Sittard-Geleen, the Netherlands

15. Academic Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands

16. Netherlands Cancer Institute, Department of Biometrics, Amsterdam, the Netherlands

17. Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam, the Netherlands

18. University Medical Center Utrecht, Department of Medical Oncology, Utrecht, the Netherlands16Netherlands Cancer Institute, Department of Medical Oncology, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3